By letter dated August 2, 2024, a Special Committee of the Board of Directors of 23andMe rejected that offer, noting that it "provide [d] no premium to the closing price per share on Wednesday, July ...
The seven independent members of the board of personal genomics company 23andMe quit Tuesday amid opposition to CEO Anne Wojcicki’s plan to take the company private.
In a letter to CEO Anne Wojcicki, the directors said they’d resign “rather than have a protracted and distracting difference of view with you” about the company’s future.
23andMe's entire board of directors resigned from the company over cofounder and CEO Anne Wojcicki's ongoing plans to take it private. In a letter to Wojcicki on Tuesday — which was also posted ...
(The Hill) — All seven independent directors of 23andMe’s board resigned on Tuesday, citing disagreements over the chief executive’s plan to take the company private. The departures leave ...